BioPharma Resources

Drug Trial Radar · NCT02197156

A Multicenter Active Comparator Study of HC-ER in Adults Following Bunionectomy Surgery

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Active Comparator Study of Hydrocodone Bitartrate Extended Release (HC-ER) in Adults Following Bunionectomy Surgery

Last checked: Nov 19, 2026Latest source record: Nov 10, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 241 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

241

Actual

Start

Aug 2002

Primary completion

Feb 2003

Study completion Feb 2003

Sponsor

Lead sponsor
Zogenix, Inc.Industry
Sponsor type
Industry
First posted
Jul 22, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Other
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to establish a dose-response relationship among several capsule strengths of Hydrocodone Bitartrate Extended Release (HC-ER) and to compare the efficacy to placebo following bunionectomy surgery

Conditions

  • Postoperative Pain

Interventions

  • 10 mg HC-ERDrug

    Single dose

  • 20 mg HC-ERDrug

    Single dose

  • 30 mg HC-ERDrug

    Single dose

  • 40 mg HC-ERDrug

    Single dose

  • 10 mg HC / 325 mg APAPDrug

    Single dose

  • Matching PlaceboDrug

    Single dose

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The Sum of Pain Intensity Differences (SPID) for the Visual Analog Scale Pain Intensity (VASPI)Time frame: 0-12 hours

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.